SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001015402-05-002589
Filing Date
2005-05-16
Accepted
2005-05-16 15:08:50
Documents
2
Period of Report
2005-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EARNINGS PRESS RELEASE FOR 1Q 2005 earnings1q2005.htm 8-K 20888
2 PRESS RELEASE 1Q 2005 pressrelease1q2005.htm EX-99.1 31077
  Complete submission text file 0001015402-05-002589.txt   53685
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 05833730
SIC: 2834 Pharmaceutical Preparations